US Edition
News from Pharmaceutical Business review
Top Pharmaceutical Business Review News
United States · United StatesOn Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously referred to as AMP-002. Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). “We look …See the Story
Why Is Amphastar Pharma Stock Soaring Tuesday? - Amphastar Pharma (NASDAQ:AMPH), Fresenius Medical Care (NYSE:FMS)
Coverage: 2 sources
Colombia · Colombia– BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria, marking key regulatory milestones in high-need emerging markets. – GMP certification in Brazil, Colombia, and Argentina spans the top three most populous countries in South America, collectively representing 71.4% of the continent’s population. – Backed by a globally recognized quality […]Read Article
